Harm Reduction 2023 Conference – Enduring Archives
Social Justice/Language Justice – 1.0 credit
National Perspectives on Harm Reduction and Community Health – 0.75 credit
Harnessing the Fury: Overcoming Barriers, Unveiling Pathways and Minimizing Harm – 0.5 credit
Drug User Health in a Syndemic Environment – 1.0 credit
October 25, 2023 to October 24, 2024
Jointly provided by Partners for Advancing Clinical Education (PACE) and HealthHIV
Estimated time to complete all modules: 3.25 hours
This activity is intended for Physicians, PAs, Pharmacists, Nurses, APRNs, Psychologists, Social Workers, Dentists and other healthcare providers who care for patients with substance use disorders or an infectious diseases(s).
Upon completion of this activity, participants should be able to:
Social Justice/Language Justice
Describe the impact of language and barriers to accessing services
Identify best practices for integrating language justice into service provisions
Describe the current environment of community relations
Describe best practices for engaging the community regarding drug user health
National Perspectives on Harm Reduction and Community Health
Explain the national harm reduction efforts and initiatives contribution to promoting community health
Describe harm reduction’s role in addressing public health challenges at the national level, such as substance use disorders and infectious diseases
Identify practical strategies and best practices in harm reduction that individuals and communities can implement to reduce harm, improve access to healthcare, and build stronger communities
Describe gaps in services needed to address the overdose crisis
Discuss harm reduction as a strategic model for addressing the overdose crisis
Harnessing the Fury: Overcoming Barriers, Unveiling Pathways and Minimizing Harm
Recognize the political impact on harm reduction and the current environment
Recognize harm reduction as a national public health issue
Identify priorities and effective advocacy strategies for harm reduction policies nationally
Describe successful models and lessons learned from harm reduction initiatives in Washington DC
Identify successful models and lessons from harm reduction initiatives in Washington DC
Drug User Health in a Syndemic Environment
Describe impact of living in a syndemic environment on overall quality of life
Describe best practices for advocating for clients to address whole person health
Faculty and Disclosure of Conflict of Interest
PACE requires planners, faculty, and others who are in a position to control the content of this activity to disclose all financial relationships they may have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to PACE policy. PACE is committed to providing learners with high-quality accredited CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following financial relationships or relationships to products or devices they have with ineligible companies:
Ken Pettigrew Director of Capacity Building HealthHIV has no relevant financial relationship(s) with ineligible companies to disclose
Leo Sheridan Capacity Building Manager has no relevant financial relationship(s) with ineligible companies to disclose
Mark Robinson Regional Syringe Service Program Manager Family and Medical Counseling Service, Inc. has no relevant financial relationship(s) with ineligible companies to disclose
Ashley Elliott, MD Clinical Psychologist & Mental Health Consultant Vivid Innovations Consulting has no relevant financial relationship(s) with ineligible companies to disclose
Sonia Canzater, JD, MPH Associate Director, Infectious Diseases Initiative O’Neill Institute for National and Global Health Law, Georgetown University Law Center has no relevant financial relationship(s) with ineligible companies to disclose
Brian Corry Public Health Advisor Division of Overdose Prevention has no relevant financial relationship(s) with ineligible companies to disclose
Jenna Bluestein Advisor, Office of Public Health and the Office of National Drug Control Policy (ONDCP) has no relevant financial relationship(s) with ineligible companies to disclose
William McColl Founder and Owner McColl Strategies, LLC has no relevant financial relationship(s) with ineligible companies to disclose
Irene Kuo, PhD, MPH Associate Research Professor George Washington University Milken Institute School of Public Health Has no relevant financial relationship(s) with ineligible companies to disclose
George S. Kerr III, MT-CDSMP/DM Founder/CEO G III Associates has no relevant financial relationship(s) with ineligible companies to disclose
Leslie Demus Unity Healthcare has no relevant financial relationship(s) with ineligible companies to disclose
The PACE planners and others have no relevant financial relationship(s) to disclose with ineligible companies. The HealthHIV planners and others have no relevant financial relationship(s) to disclose with ineligible companies.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and HealthHIV. PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
PACE designates this enduring material for a maximum of 3.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Education
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 3.25 contact hours.
Pharmacy Continuing Education
PACE designates this continuing education activity for 3.25 contact hour(s) (0.325 CEUs) of the Accreditation Council for Pharmacy Education. Type of Activity: Knowledge
Physician Assistant Continuing Education
PACE has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria.
This activity is designated for 3.25 AAPA Category 1 CME credits. Approval is valid until August 28, 2024. PAs should only claim credit commensurate with the extent of their participation.
Psychologist Continuing Education
Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.
This program offers 3.25 continuing education credits for psychologists.
Social Work Continuing Education
As a Jointly Accredited Organization, Partners for Advancing Clinical Education is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 3.25 clinical, cultural competency or general* continuing education credits.
*Social Justice/Language Justice – cultural competency
National Perspectives on Harm Reduction and Community Health – general
Harnessing the Fury: Overcoming Barriers, Unveiling Pathways and Minimizing Harm – general
Drug User Health in a Syndemic Environment – clinical
Dentist Continuing Education
PACE is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry.
PACE designates this activity for 3.25 continuing education credits.
Concerns or complaints about a CE provider may be directed to the provider, or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.